Literature DB >> 3729027

Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans.

F Donati, C Antzaka, D R Bevan.   

Abstract

The measurement of force of contraction of the adductor pollicis muscle following supramaximal stimulation of the ulnar nerve has become a standard method to assess the effect of neuromuscular blocking drugs. However, the diaphragm is regarded as resistant to these drugs, and considerable residual respiratory power might still be present after total block of adductor pollicis function. To quantify this differential effect, train-of-four stimulation was applied to the ulnar and the phrenic nerves in patients under N2O-halothane anesthesia. The force of contraction of the adductor pollicis muscle was measured with a force-displacement transducer and compared with the diaphragmatic electromyogram (EMG). Pancuronium cumulative dose-response curves for both muscles were determined in 10 ASA Class I adults. The mean dose (+/- SEM) required to depress adductor pollicis and diaphragm responses to first twitch stimulation (ED50) was 29.5 +/- 3.5 micrograms/kg and 59.5 +/- 7.0 micrograms/kg, respectively. Corresponding values for ED90 were 45 +/- 5 micrograms/kg and 95 +/- 11 micrograms/kg, respectively, indicating that the diaphragm required approximately twice as much pancuronium as the adductor pollicis block, the diaphragm was only 24 +/- 4% blocked. It is concluded that the adductor pollicis response might underestimate the degree of diaphragmatic relaxation. On the other hand, the administration of pancuronium in a dose sufficient to produce total paralysis might result in the inability to antagonize neuromuscular block in all muscles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729027     DOI: 10.1097/00000542-198607000-00001

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

Review 1.  Monitoring, new drugs, and reversal of neuromuscular blocking drugs.

Authors:  D R Bevan
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

2.  Comparison of integrated evoked EMG between the hypothenar and facial muscle groups following atracurium and vecuronium administration.

Authors:  M D Sharpe; C A Moote; A M Lam; P H Manninen
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 3.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

4.  Neuromuscular monitoring after surgery.

Authors:  D R Bevan
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 5.  Onset of action of relaxants.

Authors:  F Donati
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

Review 6.  Control of breathing: effects of analgesic, anaesthetic and neuromuscular blocking drugs.

Authors:  R L Knill
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

7.  The priming saga: where do we stand now?

Authors:  F Donati
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

Review 8.  Neuromuscular blocking drugs: practical aspects of research in the intensive care unit.

Authors:  N J Harper
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

9.  Potency of atracurium on masseter and adductor pollicis muscles in children.

Authors:  J M Saddler; J C Bevan; M H Plumley; F Donati; D R Bevan
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

10.  Different recovery of the train-of-four ratio from rocuronium-induced neuromuscular blockade in the diaphragm and the tibialis anterior muscle in rat.

Authors:  Takeshi Osawa
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.